Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.51.

  • Aytu Biopharma's Asset Utilization Ratio fell 416.77% to 0.51 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.51, marking a year-over-year decrease of 416.77%. This contributed to the annual value of 0.55 for FY2025, which is 700.39% up from last year.
  • As of Q4 2025, Aytu Biopharma's Asset Utilization Ratio stood at 0.51, which was down 416.77% from 0.51 recorded in Q3 2025.
  • In the past 5 years, Aytu Biopharma's Asset Utilization Ratio ranged from a high of 0.76 in Q2 2023 and a low of 0.24 during Q2 2021
  • Its 5-year average for Asset Utilization Ratio is 0.55, with a median of 0.54 in 2025.
  • As far as peak fluctuations go, Aytu Biopharma's Asset Utilization Ratio skyrocketed by 15820.77% in 2022, and later tumbled by 3028.31% in 2024.
  • Aytu Biopharma's Asset Utilization Ratio (Quarter) stood at 0.36 in 2021, then soared by 99.53% to 0.72 in 2022, then decreased by 5.92% to 0.68 in 2023, then decreased by 22.36% to 0.53 in 2024, then decreased by 4.17% to 0.51 in 2025.
  • Its last three reported values are 0.51 in Q4 2025, 0.51 for Q3 2025, and 0.53 during Q2 2025.